Skip to main content
Premium Trial:

Request an Annual Quote

SRA Wins $17.9M Genome Atlas Bioinformatics Contract

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SRA International has won a contract valued at up to $17.9 million from the National Institutes of Health to continue to support The Cancer Genome Atlas project, the company said yesterday.

The contract research firm, which has been working with TCGA since the project's beginning in 2006, will continue to support TCGA's Data Coordinating Center.

SRA's responsibilities as a DCC contractor include collecting, transforming, disseminating, and conducting quality assurance on all of the data generated by the more than 60 organizations that are contributing to the TGCA network including universities, cancer centers, and other private companies.

On top of its duties supporting the DCC and the TCGA data portal, under the new contract SRA will develop a Data Algorithm Repository and will provide direct bioinformatics support to the TCGA Program Office.

The first 18 months of the five-year task order are funded under the American Recovery and Reinvestment Act, and it will be worth the full $17.9 million if all options are exercised, the Fairfax, Va.-based company said.

TCGA is a joint effort by the National Cancer Institute and the National Human Genome Research Institute that is aimed at characterizing cancer tumors at the molecular level so that researchers may use that information in their efforts to develop new ways to diagnose, treat, and prevent cancer.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.